FIELD: medicine.
SUBSTANCE: invention refers to an agent for preventing and/or treating neuropathic pain containing (+) or (-) 2-[(substituted-indene-7-uloxy)methyl]morpholine of formula (I) or its pharmaceutically acceptable salt as an active ingredient. What is presented is the agent for preventing or treating allodynia, hyperalgesia, hyperesthesia, spontaneous pain, cancer-associated pain, trifacial neuralgia, phantom limb pain, postherpetic pain, fibromyalgia, low back/leg pain, thalamic pain, peripheral compression neuropathy, atypical facial pain, spinal injury accompanying pain, multiple sclerosis accompanying pain, chemotherapy induced neuropathy accompanying pain, cancer-associated pain an analgesic effect on which of a narcotic analgesic such as morphine is insufficient, diabetic neuropathy accompanying pain, etc.
EFFECT: invention provides the excellent agent for preventing or treating neuropathic pain.
4 cl
| Title | Year | Author | Number |
|---|---|---|---|
| NEW PREVENTIVE AND/OR THERAPEUTIC MEDICATION AGAINST DIABETIC NEUROPATHY | 2008 |
|
RU2465906C2 |
| (S)-PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | 2014 |
|
RU2695647C2 |
| (R)-PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | 2014 |
|
RU2695607C2 |
| SIGMA LIGANDS FOR POTENTIATING ANALGESIC EFFECT OF OPIOIDS AND OPIATES IN POSTOPERATIVE PAIN AND ATTENUATING DEPENDENCY THEREOF | 2011 |
|
RU2563460C2 |
| SIGMA-LIGANDS FOR APPLICATION IN PREVENTION AND/OR TREATMENT OF POSTOPERATIVE PAIN | 2011 |
|
RU2569055C2 |
| SIGMA-RECEPTOR LIGANDS FOR PREVENTING OR TREATING PAIN CAUSED BY CHEMOTHERAPY | 2010 |
|
RU2543382C2 |
| CRYSTALS OF CYCLIC AMINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF | 2017 |
|
RU2719384C1 |
| PREGNANDIONS OR PREGNANDIOLS APPLICATION AS NEUROPATHIC ANALGESIC AGENTS | 2002 |
|
RU2346690C2 |
| USE OF SIGMA LIGANDS IN DIABETES TYPE-2 ASSOCIATED PAIN | 2012 |
|
RU2608943C2 |
| CYSTATHIONINE-G-LYASE (CSE) INHIBITORS | 2013 |
|
RU2640418C2 |
